CS logo
small CS logo
Royal Devon & Exeter Hospital; Oncology Centre

Exeter, United Kingdom
Cancer treatment center in Exeter, England
Barrack Rd, Exeter EX2 5DW

About Royal Devon & Exeter Hospital; Oncology Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Total Rows: 1

Clinical Trials at Royal Devon & Exeter Hospital; Oncology Centre


During the past decade, Royal Devon & Exeter Hospital; Oncology Centre conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11220000Started TrialsCompleted Trails201520160123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
2007-08-30
2016-05-31
Completed
3,942
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
2016-06-07
2022-07-07
Completed
403
An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer
2016-12-12
2017-03-17
Completed
300

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Devon & Exeter Hospital; Oncology Centre" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 1Breast International Group: 1Genentech, Inc.: 1Genentech, Inc.: 1

Clinical Trials Conditions at Royal Devon & Exeter Hospital; Oncology Centre


According to Clinical.Site data, the most researched conditions in "Royal Devon & Exeter Hospital; Oncology Centre" are "Breast Cancer" (4 trials), "Bladder Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Royal Devon & Exeter Hospital; Oncology Centre" in a lesser frequency.

Clinical Trials Intervention Types at Royal Devon & Exeter Hospital; Oncology Centre


Most popular intervention types in "Royal Devon & Exeter Hospital; Oncology Centre" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (3 trials), "Paclitaxel" (3 trials), "5-Fluorouracil" (2 trials), "Carboplatin" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Devon & Exeter Hospital; Oncology Centre


The vast majority of trials in "Royal Devon & Exeter Hospital; Oncology Centre" are 7 trials for "All" genders.

Clinical Trials Status at Royal Devon & Exeter Hospital; Oncology Centre


Currently, there are NaN active trials in "Royal Devon & Exeter Hospital; Oncology Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Royal Devon & Exeter Hospital; Oncology Centre, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Royal Devon & Exeter Hospital; Oncology Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 1Active, not recruiting: 1